Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of 400 mg efavirenz versus standard 600 mg dose when taken with tenofovir and lamivudine combination in Indian adult patients with HIV-1 infection: An open-label, interventional, randomized, non-inferiority trial.
Dravid A, Pilawan AS, S A, Morkar DN, Ramapuram JT, Madhukarrao KM, Naik KS, Bhrusundi M, K R R, Nageswaramma S, Kulkarni V. Dravid A, et al. Medicine (Baltimore). 2022 Dec 2;101(48):e31982. doi: 10.1097/MD.0000000000031982. Medicine (Baltimore). 2022. PMID: 36482530 Free PMC article. Clinical Trial.
A Phase IV Study on Safety, Tolerability and Efficacy of Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate in Treatment Naïve Adult Indian Patients Living with HIV-1.
Dravid A, Morkar D, Prasad D, Ramapuram JT, Patel KV, Naik KS, Bhrusundi M, Kulkarni M, Hegde S, Anuradha S, Nageswaramma S, Madan S, Jayaprakash T, Kulkarni V. Dravid A, et al. Pragmat Obs Res. 2022 Aug 10;13:75-84. doi: 10.2147/POR.S361907. eCollection 2022. Pragmat Obs Res. 2022. PMID: 35975180 Free PMC article.
Efficacy and safety of a single-tablet regimen containing tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and efavirenz 400 mg as a switch strategy in virologically suppressed HIV-1-infected subjects on nonnucleoside reverse transcriptase inhibitor-containing first-line antiretroviral therapy in Pune, India.
Dravid A, Betha TP, Sharma AK, Gawali R, Mahajan U, Kulkarni M, Saraf C, Kore S, Dravid M, Rathod N. Dravid A, et al. HIV Med. 2020 Oct;21(9):578-587. doi: 10.1111/hiv.12912. Epub 2020 Jul 20. HIV Med. 2020. PMID: 33021066 Free PMC article.
15 results